The reckoning for big opioid makers may finally be at hand. Insys Therapeutics — which in January got slammed with court allegations that it hired an ex-stripper to perform lap dances for crooked doctors who prescribed its highly addictive fentanyl spray — disclosed Wednesday that its auditors “raised substantial doubt” about the company’s ability to...
